Clincosm LogoSign in Get a demo

epithelial ovarian cancer

Showing 26 - 50 of 166
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New York (NY-ESO-1 OLP4, NY-ESO-1 OLP4 +

Completed
Has Results
  • Epithelial Ovarian Cancer
  • +2 more
  • NY-ESO-1 OLP4
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)

Recruiting
  • Solid Tumor
  • +11 more
  • TRK-950
  • +14 more
  • Scottsdale, Arizona
  • +13 more
Oct 2, 2022

Cervical Cancer, Colorectal Cancer, Esophageal Cancer Trial (89Zr-DFO-girentuximab)

Not yet recruiting
  • Cervical Cancer
  • +13 more
  • (no location specified)
Sep 28, 2022

Epithelial Ovarian Cancer Trial in Sweden (Tinzaparin Injectable Solution)

Recruiting
  • Epithelial Ovarian Cancer
  • Tinzaparin Injectable Solution
  • Eksjö, Sweden
  • +5 more
Sep 28, 2022

Rucaparib in Rucaparib Access Program in Spain - A GEICO Study

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Almería, Andalucía, Spain
  • +22 more
Sep 22, 2022

Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer Trial in Baltimore (procedure, drug, other)

Recruiting
  • Stage III Ovarian Cancer
  • +6 more
  • Cytoreductive Surgery (CRS)
  • +6 more
  • Baltimore, Maryland
    Mercy Medical Center
Aug 30, 2022

Epithelial Ovarian Cancer Trial in Leiden ([18F]fluoro-PEG-folate PET/CT scan)

Recruiting
  • Epithelial Ovarian Cancer
  • [18F]fluoro-PEG-folate PET/CT scan
  • Leiden, Zuid-holland, Netherlands
    Leiden University Medical Center
Aug 17, 2022

Epithelial Ovarian Cancer Trial in Shanghai (LCAR-M23 cells)

Terminated
  • Epithelial Ovarian Cancer
  • LCAR-M23 cells
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Aug 15, 2022

Epithelial Ovarian Cancer, NSCLC, Renal Cell Carcinoma Trial in Saint Louis, New York (ITIL-306)

Recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • ITIL-306
  • Saint Louis, Missouri
  • +1 more
Aug 15, 2022

Epithelial Ovarian Cancer Trial in Hangzhou (Pamiparib)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Aug 4, 2022

Epithelial Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, E7777)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 4, 2022

Epithelial Ovarian Cancer Trial in Toulouse (Patients treated with platinum based-chemo)

Recruiting
  • Epithelial Ovarian Cancer
  • Patients treated with platinum based-chemotherapy
  • Toulouse, France
    Institut Universitaire du Cancer de Toulouse - Oncopole
Aug 2, 2022

Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer Trial (Pegylated Liposomal Doxorubicin +

Not yet recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • Pegylated Liposomal Doxorubicin + SL-172154
  • Mirvetuximab + SL-172154
  • (no location specified)
Jul 29, 2022

Solid Tumor, Adult, Triple Negative Breast Cancer, Colorectal Cancer Trial in Scottsdale, La Jolla, Stanford (CRX100 suspension

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • CRX100 suspension for infusion
  • Scottsdale, Arizona
  • +2 more
Jul 26, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in Santa Monica, Pittsburgh, Houston (TTI-622, Pegylated Liposomal

Recruiting
  • Ovarian Cancer
  • +5 more
  • TTI-622
  • Pegylated Liposomal Doxorubicin
  • Santa Monica, California
  • +4 more
Jul 26, 2022

Gynecologic Tumors, Epithelial Ovarian Cancer Trial in Canada, United States (PLX2853, Carboplatin)

Terminated
  • Gynecologic Neoplasms
  • Epithelial Ovarian Cancer
  • Chicago, Illinois
  • +8 more
Jul 19, 2022

Assess Safety and Effectiveness of Zirabev in Domestic Various

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +7 more
  • (no location specified)
Jun 30, 2022

Solid Tumor, TNBC - Triple-Negative Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in United States (TH1902)

Recruiting
  • Solid Tumor
  • +8 more
  • Los Angeles, California
  • +5 more
Jun 27, 2022

Ovarian Cancer, Ovarian Carcinoma, Stage II Ovary Cancer Trial in United States (Mind-body resilience training, Music therapy,

Recruiting
  • Ovarian Cancer
  • +13 more
  • Mind-body resilience training
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Jun 28, 2022

Epithelial Ovarian Cancer Trial in Jakarta, Jakarta Pusat (Vitamin D, Placebo)

Recruiting
  • Epithelial Ovarian Cancer
  • Vitamin D
  • Placebo
  • Jakarta, DKI Jakarta, Indonesia
  • +2 more
Jun 18, 2022

Epithelial Ovarian Cancer Trial in Mannheim, Essen, Hamburg (olaparib, durvalumab)

Recruiting
  • Epithelial Ovarian Cancer
  • Mannheim, Baden-Württemberg, Germany
  • +2 more
Jun 15, 2022

Epithelial Ovarian Cancer Trial (Niraparib)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • (no location specified)
May 19, 2022

Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma Trial in United States (CBX-12)

Recruiting
  • Solid Tumor, Adult
  • +11 more
  • New Haven, Connecticut
  • +3 more
May 9, 2022

Ovarian Tumor Biopsies to Study Response to Treatments

Completed
  • Epithelial Ovarian Cancer
  • Blood Draw
  • Tumor Tissue Biopsy
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 9, 2022

Epithelial Ovarian Cancer Trial in Goyang-si (HIPEC)

Recruiting
  • Epithelial Ovarian Cancer
  • HIPEC
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    Myong Cheol Lim
Apr 23, 2022